Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03373604 · ClinicalTrials.gov registry record · Phase 2
Imaging Tau in Alzheimer's Disease and Normal Aging
A Phase 2 study, sponsored by Patrick Lao.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
NCT03373604 is a Phase 2 study that has completed, run by Patrick Lao. The registered enrollment target is 71 participants.
The verdict
NCT03373604, a Phase 2 study, has completed, sponsored by Patrick Lao.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study is being done to learn about tau tangles in Alzheimer's disease. A type of positron emission tomography (PET) scan is used to measure the abnormal accumulation of protein called tau in the brain. These are thought to be involved in Alzheimer's disease. The investigators will also perform brain MRI and to tests to measure the participant's memory and thinking.
Interventions
- DRUG 18F-MK-6240
- PROCEDURE Lumbar Puncture (optional)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2017-12-11 |
| Est. Completion | 2022-05-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03373604
The ClinicalTrials.gov registry entry for NCT03373604 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Patrick Lao, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 18F-MK-6240 is the first listed.
NCT03373604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03373604 about?
NCT03373604 is a clinical study titled "Imaging Tau in Alzheimer's Disease and Normal Aging". This study is being done to learn about tau tangles in Alzheimer's disease. A type of positron emission tomography (PET) scan is used to measure the abnormal accumulation of protein called tau in the brain. These are thought to be involved in Alzheimer's disease. The investigators will also perform ...
What is the current status of trial NCT03373604?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2017-12-11. Estimated completion is 2022-05-11.
What interventions are being tested in trial NCT03373604?
The interventions under investigation include: 18F-MK-6240 (DRUG), Lumbar Puncture (optional) (PROCEDURE).
Who is sponsoring clinical trial NCT03373604?
This trial is sponsored by Patrick Lao, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.